(Total Views: 376)
Posted On: 05/29/2021 11:22:56 AM
Post# of 154687
Quote:
The longhaulers data will be compelling but will be only P2 data so it will be only able to form a future P3 trial. There could be a lack of public interest in the p2 data
Not saying it will happen. But there is a remote chance a phase 2 can be approved. Especially if it shows great efficacy. You would think the best path for that would be a BTD since there is no current drug treatment approved for LH’s. Let me state that again... remote chance it could happen. But there is that chance... just sayin...
Read More: https://investorshangout.com/post/view?id=614...z6wGdw9uuw
The longhaulers data will be compelling but will be only P2 data so it will be only able to form a future P3 trial. There could be a lack of public interest in the p2 data
Not saying it will happen. But there is a remote chance a phase 2 can be approved. Especially if it shows great efficacy. You would think the best path for that would be a BTD since there is no current drug treatment approved for LH’s. Let me state that again... remote chance it could happen. But there is that chance... just sayin...
Read More: https://investorshangout.com/post/view?id=614...z6wGdw9uuw
(1)
(0)
